MicroRNA-451a inhibits gemcitabine-refractory biliary tract cancer progression by suppressing the MIF-mediated PI3K/AKT pathway
出版年份 2023 全文链接
标题
MicroRNA-451a inhibits gemcitabine-refractory biliary tract cancer progression by suppressing the MIF-mediated PI3K/AKT pathway
作者
关键词
-
出版物
Molecular Therapy-Nucleic Acids
Volume -, Issue -, Pages 102054
出版商
Elsevier BV
发表日期
2023-10-28
DOI
10.1016/j.omtn.2023.102054
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- How I treat biliary tract cancer
- (2022) A. Lamarca et al. ESMO Open
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Epigenetic silencing of miR-144/451a cluster contributes to HCC progression via paracrine HGF/MIF-mediated TAM remodeling
- (2021) Junlong Zhao et al. Molecular Cancer
- Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial
- (2021) Angela Lamarca et al. LANCET ONCOLOGY
- MicroRNA: A signature for cancer progression
- (2021) Bashdar Mahmud Hussen et al. BIOMEDICINE & PHARMACOTHERAPY
- The current landscape of nucleic acid therapeutics
- (2021) Jayesh A. Kulkarni et al. Nature Nanotechnology
- Extracellular vesicle-shuttled miRNAs as a diagnostic and prognostic biomarker and their potential roles in gallbladder cancer patients
- (2021) Eijiro Ueta et al. Scientific Reports
- MiR-451a attenuates doxorubicin resistance in lung cancer via suppressing epithelialmesenchymal transition (EMT) through targeting c-Myc
- (2020) Li Tao et al. BIOMEDICINE & PHARMACOTHERAPY
- Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
- (2020) David S. Hong et al. BRITISH JOURNAL OF CANCER
- Cholangiocarcinoma 2020: the next horizon in mechanisms and management
- (2020) Jesus M. Banales et al. Nature Reviews Gastroenterology & Hepatology
- Therapeutic advances of miRNAs: A preclinical and clinical update
- (2020) Chiranjib Chakraborty et al. Journal of Advanced Research
- Phase 2 study of copanlisib in combination with gemcitabine and cisplatin in advanced biliary tract cancers
- (2020) Elaine S. Tan et al. CANCER
- Kras-driven heterotopic tumor development from hepatobiliary organoids
- (2019) Masako Ochiai et al. CARCINOGENESIS
- Evolving complexity of MIF signaling
- (2019) Stanislovas S. Jankauskas et al. CELLULAR SIGNALLING
- miRDB: an online database for prediction of functional microRNA targets
- (2019) Yuhao Chen et al. NUCLEIC ACIDS RESEARCH
- miRPathDB 2.0: a novel release of the miRNA Pathway Dictionary Database
- (2019) Tim Kehl et al. NUCLEIC ACIDS RESEARCH
- Impact of novel oncogenic pathways regulated by antitumor miR-451a in renal cell carcinoma
- (2018) Yasutaka Yamada et al. CANCER SCIENCE
- EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration
- (2018) Nicole M. Aiello et al. DEVELOPMENTAL CELL
- miRBase: from microRNA sequences to function
- (2018) Ana Kozomara et al. NUCLEIC ACIDS RESEARCH
- Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study
- (2017) Nico van Zandwijk et al. LANCET ONCOLOGY
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- FolamiRs: Ligand-targeted, vehicle-free delivery of microRNAs for the treatment of cancer
- (2017) Esteban A. Orellana et al. Science Translational Medicine
- Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2016) J. W. Valle et al. ANNALS OF ONCOLOGY
- 3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained
- (2016) Michele Zanoni et al. Scientific Reports
- Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer
- (2015) Tejaswini Subbannayya et al. BMC CANCER
- SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway
- (2015) Yi-Jun Shu et al. Molecular Cancer
- Genomic spectra of biliary tract cancer
- (2015) Hiromi Nakamura et al. NATURE GENETICS
- MYC, Metabolism, and Cancer
- (2015) Z. E. Stine et al. Cancer Discovery
- Spherical Cancer Models in Tumor Biology
- (2015) Louis-Bastien Weiswald et al. NEOPLASIA
- Macrophage migration inhibitory factor engages PI3K/Akt signalling and is a prognostic factor in metastatic melanoma
- (2014) Camila S Oliveira et al. BMC CANCER
- MicroRNA-451 induces epithelial–mesenchymal transition in docetaxel-resistant lung adenocarcinoma cells by targeting proto-oncogene c-Myc
- (2014) Dongqin Chen et al. EUROPEAN JOURNAL OF CANCER
- Signaling mechanisms of the epithelial-mesenchymal transition
- (2014) D. M. Gonzalez et al. Science Signaling
- Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells
- (2013) Ingrid Espinoza et al. CANCER LETTERS
- Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells
- (2013) NADÈGE KINDT et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The Potential Role of miR-451 in Cancer Diagnosis, Prognosis, and Therapy
- (2013) X. Pan et al. MOLECULAR CANCER THERAPEUTICS
- Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy
- (2013) Supak Yothaisong et al. TUMOR BIOLOGY
- Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma
- (2012) Naotake Funamizu et al. INTERNATIONAL JOURNAL OF CANCER
- Activation of the AKT/cyclin D1/Cdk4 survival signaling pathway in radioresistant cancer stem cells
- (2012) T Shimura et al. Oncogenesis
- Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549)
- (2011) Hai-Bo Bian et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Cholangiocarcinoma—controversies and challenges
- (2011) Tushar Patel Nature Reviews Gastroenterology & Hepatology
- MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14)
- (2011) R Wang et al. ONCOGENE
- The Promise of MicroRNA Replacement Therapy
- (2010) A. G. Bader et al. CANCER RESEARCH
- Defective erythroid differentiation in miR-451 mutant mice mediated by 14-3-3
- (2010) D. M. Patrick et al. GENES & DEVELOPMENT
- Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
- (2010) Louis Vermeulen et al. NATURE CELL BIOLOGY
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of PI3K increases oxaliplatin sensitivity in cholangiocarcinoma cells
- (2009) Kawin Leelawat et al. Cancer Cell International
- The Expression of Phospho-AKT, Phospho-mTOR, and PTEN in Extrahepatic Cholangiocarcinoma
- (2009) J.-Y. Chung et al. CLINICAL CANCER RESEARCH
- Expression of phospho-ERK1/2 and PI3-K in benign and malignant gallbladder lesions and its clinical and pathological correlations
- (2009) Qinglong Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells
- (2009) Kyoung-Ok Hong et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Spheroid-based drug screen: considerations and practical approach
- (2009) Juergen Friedrich et al. Nature Protocols
- MicroRNAs in Cancer
- (2008) Yong Sun Lee et al. Annual Review of Pathology-Mechanisms of Disease
- The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations
- (2008) A. Dubrovska et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PI-3K/Akt Pathway-Dependent Cyclin D1 Expression Is Responsible for Arsenite-Induced Human Keratinocyte Transformation
- (2007) Weiming Ouyang et al. ENVIRONMENTAL HEALTH PERSPECTIVES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started